Conjugate vaccine
Is 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Combined With 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) Superior to PPSV23 Alone for Reducing Incidence or Severity of Pneumonia in Older Adults? A Clin-IQ
... Abstract Pneumonia infection is a significant cause of morbidity and mortality worldwide. In addition to the public health concerns, pneumonia also accounts for a significant cost to the health care system. Currently ...
6
Priming of Immunological Memory by Pneumococcal Conjugate Vaccine in Children Unresponsive to 23-Valent Polysaccharide Pneumococcal Vaccine
... polysaccharide vaccine (PPV) is of limited immunogenicity in infants and immunocompro- mised ...pneumococcal conjugate vaccine (PCV) induced specific immunological memory in previously nonresponders ...
7
Cost effectiveness analysis of pneumococcal conjugate vaccine 13 valent in older adults in Colombia
... pneumococcal vaccine with a different tech- nology was launched, which conjugates pneumococcal serotypes with a diphtheria protein ...pneumococcal conjugate vaccine 7-valent (PCV7) that demonstrated ...
9
Haemophilus influenzae Type b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIBTM): Clinical Evaluation
... Haemophilus b conjugate vaccine (meningococcal protein conjugate), PedvaxHlBa (PRP-OMPC), is a con- jugate H influenzae type b vaccine developed at Merck Sharp & Dohme Research Labor[r] ...
8
A Poly N Acetylglucosamine−Shiga Toxin Broad Spectrum Conjugate Vaccine for Shiga Toxin Producing Escherichia coli
... tion (Fig. 4). All mice pretreated with the control NRS became moribund or died within 76 h of STEC inoculation, whereas 60 to 80% mice pretreated with the antisera from the PNAG-Stx1b im- mune rabbits were alive 120 h ...
9
Salivary antibodies induced by the seven valent PncOMPC conjugate vaccine in the Finnish Otitis Media Vaccine Trial
... a conjugate booster [14,22,34]. However, a conjugate vaccine as a booster can be favourable for the persistence and quality of antibodies, because it stimu- lates the formation of high-affinity ...
8
Immune Response in Infants to the Heptavalent Pneumococcal Conjugate Vaccine against Vaccine-Related Serotypes 6A and 19A
... pneumococcal conjugate vaccine (PCV7) elicits good immune response to and is effective against vaccine ...against vaccine-related serotypes is ...(seven vaccine serotypes and serotype ...
6
Pneumococcal conjugate vaccine implementation in middle-income countries
... Accelerated vaccine introduction; CDC: Center for Disease Prevention and Control; DTP3: Diphtheria-tetanus- pertussis; GAPPD: Integrated Global Action Plan for the Prevention and Control of Pneumonia and ...
15
Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine
... monovalent vaccine is that virulent isolates expressing the capsule targeted by the vaccine may take up genes coding for another capsule by horizontal gene transfer and evade the im- mune system ...
10
Safety, Tolerability, and Immunogenicity of Concurrent Administration of Haemophilus influenzae Type b Conjugate Vaccine (Meningococcal Protein Conjugate) With Either Measles-Mumps-Rubella Vaccine or Diphtheria-Tetanus-Pertussis and Oral Poliovirus Vaccines in 14-to 23-Month-Old Infants
... Subjects in group 1 were given the H influenzae type b conjugate vaccine (0.5 mL intramuscularly in the right anterior thigh muscle) concurrently with the DTP vaccine (0.5 mL intramuscul[r] ...
10
Influence of Insurance Status and Vaccine Cost on Physicians’ Administration of Pneumococcal Conjugate Vaccine
... practice for whom purchase of PCV7 is paid for by private health insurance, VFC, or a state vaccination program (“insurance cov- erage”). They were then asked to specify the site at which they administer PCV7 for ...
8
Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease
... Europe in 2012. The immunogenicity of MenACWY-TT, its reactogenicity and safety profile, as well as its coadministration with other vaccines are discussed in this review. Clinical trials showed that MenACWY-TT was ...
15
Pneumococcal Conjugate Vaccine Breakthrough Infections: 2001–2016
... vaccination schedule included PCV7 versus PCV13 breakthrough infection, age at infection, birth year, case calendar year, infection serotype, state where case occurred, interaction between age at infection and case ...
14
Immunogenicity of a New Haemophilus influenzae Type b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIBTM)
... when challenged with a virulent H influenzae type b strain isolated from a human clinical case of H influenzae type b meningitis (Table 7); the histo- pathology observed in rats is simil[r] ...
10
Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine
... Immunogenicity data for PCV7 and PCV13 were reported as serotype- specific antipolysaccharide geometric mean IgG antibody concentrations (GMCs) with 2-sided 95% confidence intervals (CIs). The proportions of in- fants who ...
12
Haemophilus influenzae Type b Conjugate Vaccine (Meningicoccal Protein Conjugate): Immunogenicity and Safety at Various Doses
... effect of dose of PRP-OMPC on anti-PRP antibody levels in children and infants as young as 2 months of age.. In addition, the safety of PRP-OMPC at different doses was.[r] ...
6
Physician Perspectives Regarding Pneumococcal Conjugate Vaccine
... the vaccine for reasons that were ultimately related to financial ...purchased vaccine via the VFC program, delays were related to availability of the vaccine through the VFC ...Pneumococcus, ...
9
Haemophilus influenzae Type b Conjugate Vaccine
... Berkowitz CD, Ward JI, Hendley JO, et al: Persistence of antibody (ab) to Haemophilus influenzae type b (Hib) and response to PRP and PRP-D booster immunization in chil- dren initially i[r] ...
6
Understanding how ESOL Pre Services Teachers' Prior Experiences and Background Shape their Processes of becoming L2 (Reading) Teachers
... An important factor to assess during pre-licensure is the detail evaluation of vaccine safety. For PCV7 and PCV13 no major safety problems were identified, however it is impossible to identify all safety concerns ...
49
Febrile Seizures After 2010–2011 Trivalent Inactivated Influenza Vaccine
... All con fi rmed FS with vaccines identi fi ed in claims or registry data or in medical records were included in the main analysis. We excluded cases if live attenuated influenza vaccine (LAIV) or 7-valent ...
10